Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 453 - Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
Patents for C07D 453 - Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids (5,704)
05/1996
05/17/1996WO1996014316A1 A method of treating urinary bladder dysfunctions
05/15/1996EP0711299A1 AZABICYCLOALKYL DERIVATIVES OF IMIDAZO(1,5-a)INDOL-3-ONE AS 5HT 3 ANTAGONISTS
05/15/1996EP0711292A1 Aza spiro compounds acting on the cholinergic system with muscarinic agonist activity
05/14/1996US5516929 Using alkaloid aromatic ether derivatives of dihydroquinine and dihydroquinidine along with osmium compound, base, and potassium ferricyanide
05/09/1996WO1996013168A1 Method for treating anxiety
05/09/1996WO1996013166A1 Method for treating anxiety
05/09/1996CA2202781A1 Method for treating anxiety
05/08/1996EP0710236A1 Azalicyclooctane derivatives as anti-arrhythmic agents
05/08/1996CN1121806A Pharmaceutical agents for treatment of emesis
05/07/1996US5514812 Preparation of stereochemically pure oximes with muscarinic activity
05/07/1996CA1338314C Ligand-accelerated catalytic asymmetric dihydroxylation
05/02/1996WO1996012717A1 Potentiator for nerve growth factor activity containing 1,2-ethanediol derivative or salt thereof
05/02/1996WO1996012711A1 Heterocyclic compounds and their use
05/02/1996WO1996012486A1 Use of [r-(z)]-alpha-(methoxyimino)-alpha-(1-azabicyclo [2.2.2] oct-3-yl) acetonitrile to reduce amyloid beta a4 formation in alzheimer's disease
05/02/1996WO1996012479A1 Use of nk1 receptor antagonists for preparing cardio-regulatory drugs
05/02/1996CA2203426A1 Heterocyclic compounds and their use
05/02/1996CA2203271A1 Use of nk1 receptor antagonists for preparing cardio-regulatory drugs
05/01/1996EP0709381A1 Heterocyclic compounds and their preparation and use
05/01/1996EP0709095A2 Method for treating anxiety using a tetrahydropyridine or azabicyclic oxadiazole or thiadiazole compound
05/01/1996EP0709093A2 Method for treating anxiety using an azabicyclic oxadiazole or thiadiazole compound
05/01/1996EP0708771A1 Benzyloxyquinuclidines as substance p antagonists
05/01/1996EP0708765A1 Substituted piperazinylcamphor derivatives as oxytocin antagonists
05/01/1996CN1121718A Heterocyclic derivatives
04/1996
04/30/1996US5512574 Treating neurological and mental illnesses, such as alzheimer's
04/30/1996US5512553 Preventing or treating bacterial infections
04/25/1996CA2161176A1 Heterocyclic compounds and their preparation and use
04/24/1996CN1121349A Heterocyclic compounds and their preparation and use
04/23/1996US5510486 Process for preparing 2-(1-azabicyclo 2.2.2!oct-3-yl)-2,3,3A,4,5,6-hexahydro-1H-benz de!isoquinolin-1-one
04/23/1996US5510478 Treatment of neurological illnesses related to cholinergic deficiency; alzheimers's disease
04/23/1996US5510380 Nonpeptide bradykinin antagonists
04/23/1996US5510355 Depolarizing skeletal muscle relaxants
04/16/1996US5508405 Quinuclidines, their use as medicaments and processes for their preparation
04/09/1996US5506237 Bicyclic nitrogen compounds
03/1996
03/26/1996US5502165 Process for peptide segment condensation
03/21/1996WO1996008473A1 Improved process for r (+) 1,2,3,6-tetrahydro-4-phenyl-1-[(3-phenyl-3-cyclohexen-1-yl)methyl]pyridine, a central nervous system agent
03/21/1996CA2194000A1 Improved process for r (+) 1,2,3,6-tetrahydro-4-phenyl-1-¬(3-phenyl-3-cyclohexen-1-yl)methyl|pyridine, a central nervous system agent
03/14/1996WO1996007410A2 Depolarizing skeletal muscle relaxants
03/13/1996EP0700386A1 Neurokinin receptor antagonists
03/13/1996EP0700382A1 Novel n-arylaliphatic-n-alkyl-functionalised amides, method for their prepation and pharmaceutical compositions containing same
03/06/1996EP0699199A1 Heteroatom substituted alkyl benzylaminoquinuclidines as substance p antagonists
03/06/1996EP0699186A1 Indole derivatives as antagonists of excitatory amino acids
03/06/1996EP0587723B1 Quinuclidine derivatives
02/1996
02/29/1996WO1996006098A1 Spiro-azabicyclic compounds useful in therapy
02/29/1996WO1996006083A1 2-(piperazinyl-1-carbonylmethyl)-1,4-dihydropyridines as bradykinin antagonists
02/29/1996WO1996006082A1 Dihydropyridine derivatives as bradykinin antagonists
02/29/1996WO1996006081A1 Neuroprotective 3-(piperidinyl-1)-chroman-4,7-diol and 1-(4-hydrophenyl)-2-(piperidinyl-1)-alkanol derivatives
02/28/1996EP0659184B1 Optically active hydroquinine (amino-3 phenyl)-1 ethanesulfonate, preparation and use thereof
02/28/1996EP0494978B1 Heterocyclic compounds
02/27/1996US5495018 7-(substituted-9-(substituted amino)-6-demethyl-6-deoxytetracyclines
02/27/1996US5494918 Anticholesterol agents
02/27/1996US5494917 Cognition enhancing quinuclidine compound
02/20/1996US5492920 Piperidine, pyrrolidine and hexahydro-1H-azepines promote release of growth hormone
02/20/1996US5492915 Substituted quinolyl compounds exhibiting selective leukotriene B4 antagonist activity
02/20/1996US5492914 2-(1-azabicyclo[2.2.2]oct-3 s-yl)-6-hydroxy-2,4,5,6-tetrahydro-1H-benz[DE]is[2.2.2]oct-3's-yl)-6-hydroxy-2,3,3a,4,5,6-hexahydro-1h-benz [DE]isoquinolin-1-one and individual stereoisomers thereof
02/20/1996US5492908 Antiarthritic
02/14/1996EP0696284A1 Heterocyclic derivatives
02/13/1996US5491148 Treating gastrointestinal, cardiovascular, central nervous system disorders, emesis, pain
02/08/1996WO1996003123A1 Methods
01/1996
01/30/1996US5488056 Method for treating anxiety
01/25/1996WO1996001824A1 Process for the preparation of 2-(1-azabicyclo(2.2.2)oct-3-yl) -2,4,5,6-tetrahydro-1h-benz(de)isoquinolin-1-one and intermediate product
01/25/1996WO1996001630A1 Preventive or remedy for irritable bowel syndrome or diarrhea
01/16/1996US5484794 Thia- or oxa-diazole compounds
01/09/1996US5482957 Azole derivatives, process for their preparation and their use
01/09/1996US5482938 Azabicyclo and azacyclo oxime and amine cholinergic agents and methods of treatment
01/03/1996EP0689549A1 New urea derivates, their preparation and their use
12/1995
12/28/1995WO1995035295A1 Quinuclidine derivatives as squalene synthase inhibitors
12/26/1995CA1337817C Heterocyclic spiro compounds and methods for preparing the same
12/21/1995WO1995034562A1 Preparation of stereochemically pure oximes with muscarinic activity
12/20/1995EP0687266A1 Heterocyclic compounds and their preparation and use
12/07/1995WO1995032965A1 Oxadiazole derivative and medicinal composition thereof
12/07/1995WO1995032949A1 Gastrin and cck antagonists
12/05/1995US5472984 1,2-ethanediol derivative and salt thereof and cerebral function-improving agent comprising the same
11/1995
11/30/1995WO1995032209A1 AZABICYCLOALKYL DERIVATIVES OF IMIDAZO(1,5-a)INDOL-3-ONE AS 5HT3 ANTAGONISTS
11/30/1995CA2166621A1 Azabicycloalkyl derivatives of imidazo(1,5-a)indol-3-one and process for their preparation
11/28/1995US5470859 Azabicyclic compounds with muscarinic activity useful for treating dementia
11/23/1995WO1995031458A1 3-hydroxyquinuclidin-3-ylphenylquinolines as squalene synthase inhibitors
11/23/1995WO1995031457A1 Derivatives of quinuclidine n-oxide as muscarinic receptor ligands
11/23/1995WO1995031456A1 Process for the preparation of azabicyclic derivatives
11/23/1995CA2190278A1 Process for the preparation of azabicyclic derivatives
11/22/1995EP0683168A1 Method for producing 2-methylspiro(1,3-oxathiolane-5,3')quinuclidine
11/16/1995WO1995030675A1 Biphenylcarboxamides useful as 5-ht1d antagonists
10/1995
10/31/1995US5463105 Therapy for cardiovascular, nervous system disorders
10/24/1995CA1337415C Indole derivatives
10/19/1995WO1995027727A2 Process for peptide segment condensation
10/19/1995CA2186605A1 Process for peptide segment condensation
10/17/1995US5459161 Cognition activators
10/17/1995CA1337347C Benzimidazoline-2-one-1-carboxylic acid derivatives useful as 5-ht receptor antagonists
10/05/1995WO1995026338A1 Neurokinin receptor antagonists
10/05/1995WO1995026335A1 Novel n-arylaliphatic-n-alkyl-functionalised amides, method for their preparation and pharmaceutical compositions containing same
10/04/1995EP0674637A1 Quinuclidine derivatives as squalene synthase inhibitors
10/04/1995EP0674636A1 Quinuclidine derivatives as squalene synthase inhibitors
10/04/1995EP0674635A1 Quinuclidine derivatives as squalene synthase inhibitors
10/04/1995EP0674623A1 Bicyclic fibrinogen antagonists
10/03/1995US5455243 Fibrinogen receptor antagonists for inhibiting aggregation of blood platelets
10/03/1995CA1337199C Five-membered ring systems with bonded azacyclic ring substituents
09/1995
09/27/1995EP0395729B1 Ligand-accelerated catalytic asymmetric dihydroxylation
09/19/1995US5451587 3-(2-propynyloxy)-1-azabicyclo(2.2.2)octane for treating alzheimer*s disease
09/19/1995US5451586 Substance P antagonist
09/13/1995CN1108240A Excitatory amino acid receptor antagonists
09/12/1995US5449778 Peptide intermediates
1 ... 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 ... 58